Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 5/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8590568 | 1.00 | HSP90AA1 (0.55) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL8945838 | 1.00 | HSP90AA1 (0.55) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL7157837 | 1.00 | HSP90AA1 (0.55) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL9305133 | 1.00 | HSP90AA1 (0.55) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL8423003 | 1.00 | HSP90AA1 (0.55) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL9063066 | 0.94 | POLB (0.53) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL9063056 | 0.94 | POLB (0.53) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL9063256 | 0.94 | POLB (0.53) | HSP90AA1FAAHDGKALMNAMAPK1 | |
| SCHEMBL8362365 | 0.93 | GPR84 (0.59) | LMNAMEN1KMT2APOLBPAM | |
| SCHEMBL27344241 | 0.93 | HSP90AA1 (0.48) | HSP90AA1FAAHDGKALMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11608320-B2 | Oxazolidinone hydroxamic acid derivatives | KUWAIT UNIVERSITY (KW) | 2023-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11608320-B2 | Oxazolidinone hydroxamic acid derivatives | ALOX5, ALOX15, ALOX15B | HSP90AA1 1148/4885FAAH 248/4885DGKA 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.